Research & development > Clinical diagnostics

Diagnostic test for schistosomiasis on the horizon

01 December, 2021

To interrupt the spread of the disease, a test needs to be sensitive enough to identify people with low-level infections.

Blood tests predict chemo resistance in prostate cancer patients

22 November, 2021

The findings could enable doctors to detect early on if a treatment is working and switch to alternatives such as abiraterone or cabazitaxel if it is not.

A urine test for intermediate-risk prostate cancer

08 November, 2021

A prostate cancer urine test can identify men at intermediate risk of aggressive disease, who can safely avoid immediate treatment.

Saliva testing may allow early detection of HPV-driven cancers

21 October, 2021

Researchers investigated the efficacy of salivary HPV detection as a biomarker of HPV-driven head and neck cancers.

No more liver biopsies for haemochromatosis patients?

30 August, 2021

Liver damage caused by a life-threatening genetic blood disorder, known as hereditary haemochromatosis, can be detected with a simple blood test or scan.

Test to better detect early-stage ovarian cancer

30 July, 2021

A new test could help reduce the high mortality rate from ovarian cancer by dramatically improving the accuracy of early detection.

One-hour Hendra test developed for horses

23 July, 2021

Vets have developed a diagnostic point-of-care kit that is claimed to detect the deadly Hendra virus in horses faster than ever — in under an hour, rather than days.

Blood test could help diagnose frontotemporal dementia

16 July, 2021

Blood-based measurement of glial fibrillary acidic protein (GFAP) can distinguish patients with frontotemporal dementia from those with primary psychiatric disorders or healthy individuals.

Rapid malaria test kit useful for developing countries

07 July, 2021

The kit could facilitate the diagnosis of malaria in the field, as it is anticipated to be lightweight, easy to use and able to detect the disease in its early stages.

Blood test enables early detection of >50 types of cancer

06 July, 2021

Many of the cancers that the test is capable of detecting do not have screening tests available, such as liver, pancreatic and oesophageal cancers.

Odour test sniffs out hard-to-detect cancers

15 June, 2021

The odour-based test sniffs out vapours emanating from blood samples and is able to distinguish between benign, pancreatic and ovarian cancer cells.

One-second test for COVID-19 biomarkers

25 May, 2021

Researchers have developed a rapid and sensitive testing method for COVID-19 biomarkers, claimed to provide results in just one second.

Prostate cancer urine test indicates disease aggression

28 April, 2021

An experimental new urine test for prostate cancer has the potential to revolutionise how patients with suspected prostate cancer are risk-assessed prior to an invasive biopsy.

Assay enables fast diagnosis of liposarcomas

11 February, 2021

Researchers have developed a gene panel test that allows for highly accurate diagnosis of the most common types of liposarcoma.

Aus biotech company supplies at-home COVID-19 tests to US

03 February, 2021 by Lauren Davis

Queensland-based company Ellume has announced a US$231.8 million (AU$302.7 million) agreement to accelerate domestic US production of its COVID-19 home tests.

  • All content Copyright © 2021 Westwick-Farrow Pty Ltd